Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125760521 | 12576052 | 1 | I | 20160622 | 20160718 | 20160720 | 20160720 | EXP | PHHY2016VE099420 | NOVARTIS | 56.64 | YR | M | Y | 0.00000 | 20160720 | CN | COUNTRY NOT SPECIFIED | VE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125760521 | 12576052 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Unknown | 30 MG, QMO | 21008 | 30 | MG | /month | |||||||
125760521 | 12576052 | 2 | SS | ZOMETA | ZOLEDRONIC ACID | 1 | Unknown | 4 MG, QMO | 0 | 4 | MG | SOLUTION FOR INJECTION | /month | ||||||
125760521 | 12576052 | 3 | C | INSULIN | INSULIN NOS | 1 | Unknown | UNK UNK, QD | 0 | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125760521 | 12576052 | 1 | Neuroendocrine tumour |
125760521 | 12576052 | 2 | Product used for unknown indication |
125760521 | 12576052 | 3 | Diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125760521 | 12576052 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125760521 | 12576052 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |